Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin versus amoxicillin-clavulanic acid for childhood bronchiectasis exacerbations
ACTRN12612000010897Phase 4Completed
- Sponsor
- Child Health Research Centre
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in bronchiectasis comparing Azithromycin arm with Amoxicillin-clavulanic acid arm (2 arms). Primary endpoint: Resolution of respiratory exacerbation. Started Oct 2012; status: completed.
02
Drugs
azithromycinamoxicillin + clavulanate
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on ACTRN12612000010897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000010897.